A homozygous stop codon in the lysyl hydroxylase gene in two siblings with Ehlers-Danlos syndrome type VI. 1992

J Hyland, and L Ala-Kokko, and P Royce, and B Steinmann, and K I Kivirikko, and R Myllylä
Collagen Research Unit, University of Oulu, Finland.

Ehlers-Danlos syndrome (EDS) is characterized by joint hypermobility, alterations in the skin and additional signs of connective tissue involvement. EDS type VI was the first connective tissue disorder for which a specific defect in collagen metabolism was identified, namely a deficiency of lysyl hydroxylase activity. We now report a homozygous single basepair substitution converting the CGA codon (Arg319) to a TGA termination codon in two siblings with EDS type VI. The healthy parents, who are first cousins, and two of the three healthy siblings of the patients are heterozygous. The mutation leads to an almost complete absence of lysyl hydroxylase activity in extracts derived from fibroblasts of the patients.

UI MeSH Term Description Entries
D008240 Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase A mixed-function oxygenase that catalyzes the hydroxylation of peptidyllysine, usually in protocollagen, to peptidylhydroxylysine. The enzyme utilizes molecular oxygen with concomitant oxidative decarboxylation of the cosubstrate 2-oxoglutarate to succinate. EC 1.14.11.4. Lysine 2-Oxoglutarate Dioxygenase,Lysine Hydroxylase,Protocollagen Lysyl Hydroxylase,Collagen Lysyl Hydroxylase,Lysyl Hydroxylase,2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine,2-Oxoglutarate Dioxygenase, Lysine,5-Dioxygenase Procollagen-Lysine, 2-Oxoglutarate,Dioxygenase, Lysine 2-Oxoglutarate,Hydroxylase, Collagen Lysyl,Hydroxylase, Lysine,Hydroxylase, Lysyl,Hydroxylase, Protocollagen Lysyl,Lysine 2 Oxoglutarate Dioxygenase,Procollagen Lysine, 2 Oxoglutarate 5 Dioxygenase
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003241 Consanguinity The magnitude of INBREEDING in humans. Inbreeding, Human,Consanguineous Marriage,Consanguinous Mating,Consanguineous Marriages,Consanguinities,Consanguinous Matings,Human Inbreeding,Human Inbreedings,Inbreedings, Human,Marriage, Consanguineous,Marriages, Consanguineous,Mating, Consanguinous,Matings, Consanguinous
D004535 Ehlers-Danlos Syndrome A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability. Cutis Elastica,Ehlers Danlos Disease,Ehlers-Danlos Disease,Danlos Disease, Ehlers,Disease, Ehlers Danlos,Disease, Ehlers-Danlos,Ehlers Danlos Syndrome,Syndrome, Ehlers-Danlos
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes

Related Publications

J Hyland, and L Ala-Kokko, and P Royce, and B Steinmann, and K I Kivirikko, and R Myllylä
May 1999, Molecular genetics and metabolism,
J Hyland, and L Ala-Kokko, and P Royce, and B Steinmann, and K I Kivirikko, and R Myllylä
April 2001, The Journal of investigative dermatology,
J Hyland, and L Ala-Kokko, and P Royce, and B Steinmann, and K I Kivirikko, and R Myllylä
February 1993, Genomics,
J Hyland, and L Ala-Kokko, and P Royce, and B Steinmann, and K I Kivirikko, and R Myllylä
September 1989, The Journal of pediatrics,
J Hyland, and L Ala-Kokko, and P Royce, and B Steinmann, and K I Kivirikko, and R Myllylä
October 1999, Human mutation,
J Hyland, and L Ala-Kokko, and P Royce, and B Steinmann, and K I Kivirikko, and R Myllylä
April 1994, The Journal of clinical investigation,
J Hyland, and L Ala-Kokko, and P Royce, and B Steinmann, and K I Kivirikko, and R Myllylä
April 1998, Archives of dermatological research,
J Hyland, and L Ala-Kokko, and P Royce, and B Steinmann, and K I Kivirikko, and R Myllylä
October 1980, Biochemical and biophysical research communications,
J Hyland, and L Ala-Kokko, and P Royce, and B Steinmann, and K I Kivirikko, and R Myllylä
July 1984, American journal of human genetics,
J Hyland, and L Ala-Kokko, and P Royce, and B Steinmann, and K I Kivirikko, and R Myllylä
September 1976, Archives of ophthalmology (Chicago, Ill. : 1960),
Copied contents to your clipboard!